| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 19.32M | 14.24M | 12.17M | 12.47M | 17.18M |
| Gross Profit | 3.90M | 4.10M | 2.64M | 3.38M | 2.71M |
| EBITDA | -1.45M | -383.00K | -2.71M | -6.14M | -2.56M |
| Net Income | -2.17M | -1.15M | -5.43M | -6.74M | -6.27M |
Balance Sheet | |||||
| Total Assets | 45.89M | 9.89M | 11.31M | 15.67M | 31.32M |
| Cash, Cash Equivalents and Short-Term Investments | 15.64M | 3.08M | 3.56M | 6.91M | 15.22M |
| Total Debt | 19.50M | 1.66M | 1.60M | 1.80M | 2.06M |
| Total Liabilities | 43.00M | 7.32M | 7.52M | 6.38M | 15.53M |
| Stockholders Equity | 2.43M | 2.56M | 3.79M | 9.29M | 15.79M |
Cash Flow | |||||
| Free Cash Flow | -860.80K | 261.00K | -3.12M | -8.13M | -3.69M |
| Operating Cash Flow | -812.88K | 337.00K | -2.85M | -4.68M | -712.00K |
| Investing Cash Flow | 11.18M | 12.00K | -187.00K | -3.41M | -2.79M |
| Financing Cash Flow | 1.53M | -475.00K | -392.00K | -358.00K | -284.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | HK$412.84M | -0.34 | 3.70% | 9.12% | 27.05% | 842.50% | |
65 Neutral | HK$190.44M | 5.58 | 3.33% | 3.33% | 8.45% | -30.47% | |
62 Neutral | HK$308.20M | -647.80 | 3.68% | 7.24% | -1.26% | -10.80% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
48 Neutral | HK$313.89M | -5.04 | -16.07% | ― | -9.21% | -4.52% | |
46 Neutral | HK$149.76M | -2.39 | -31.93% | ― | -78.41% | -3530.77% | |
42 Neutral | HK$383.76M | -150.95 | -91.18% | ― | 29.99% | -113.64% |